BioCentury
ARTICLE | Company News

EC approves Avanir's Nuedexta

June 26, 2013 12:29 AM UTC

Avanir Pharmaceuticals Inc. (NASDAQ:AVNR) said the European Commission approved an MAA for Nuedexta dextromethorphan/quinidine to treat pseudobulbar affect (PBA), irrespective of underlying neurologic...